On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.
↑ XThis proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.
Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), LeMaitre Vascular (LMAT) and Insulet (PODD) are among the top 5 highly rated stocks within the group.
YOU MAY ALSO LIKE:
MarketSurge's Tools Can Help The Individual Investor
IBD Live: A New Tool For Daily Stock Market Analysis
Profit From Short-Term Trends With SwingTrader
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.